Ó³»­´«Ã½

Count Me In (CMI), an initiative focused on patient-partnered cancer research, has announced the launch of a new cohort for individuals with hepatocellular carcinoma (HCC) and HCC-like tumors.

Long-standing industry-academia collaboration has already resulted in three clinical oncology candidates.

The small molecule, now in clinical trials, increases activity of immune cells and sensitivity of tumors to immune attack.

Researchers identify protein modifications that underlie many key cancer processes.

An analysis of nearly 11,000 human cancers revealed how large chromosomal changes, called aneuploidies, can promote or slow the growth of tumors.

New study looks at gut microbes' influence, findings may help with prevention

Study provides one of the first descriptions of the genetic evolution of cancers that develop in multiple tissues in the body

A study of tumor exomes reconstructs a timeline of mutations for certain cancer types, revealing insight into the order of genetic drivers of the disease. 

By integrating clinical, genetic, and other data from patients with lung cancer, researchers identify biological factors that could help predict treatment outcomes.

Study findings may help researchers predict which patients with tumors may benefit from certain drug candidates.